Navigation Links
Nebulizer in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

... COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were ... researchers chose PARI products as the exclusive nebulizer systems for recent studies comparing maintenance ... to placebo/tiotropium. The PARI LC Plus nebulizer and PARI PRONEB Ultra compressor were used ...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

... once daily for 28 days using an eFlow(R) nebulizer System (PARI Pharma GmbH), a novel, highly ... About PARI Pharma and the eFlow (R) nebulizer System ARIKACE is delivered by an eFlow nebulizer System developed by PARI Pharma GmbH. The ...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

... for L-CsA, delivered via an Investigational eFlow nebulizer System, for the prevention and treatment of ... for administration via an Investigational eFlow nebulizer System without destroying the liposome," stated ... dose of 10mg L-CsA with an Investigational eFlow nebulizer System would give approximately 14 mg L-CsA/week. ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... a customized small droplet Investigational eFlow nebulizer System designed to deliver drugs to the deep ... (MMAD ~ 3.3 microns) Investigational eFlow nebulizer System has similar effects on asthma control, ... when administered via the Investigational eFlow nebulizer System," said Prof. Johannes Wildhaber, principal ...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

... inhalation solution delivered via PARI's LC STAR nebulizer and PRONEB Ultra compressor for the treatment of ... The combination of PARI's LC STAR breath-enhanced nebulizer and PRONEB Ultra compressor provides for a quick ... the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award-winning ...

PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study

... /PRNewswire/ -- An optimized PARI eFlow platform nebulizer will be delivering Alnylam's ALN-RSV01 in a Phase ... . About eFlow eFlow, an electronic, portable nebulizer platform, enables extremely efficient ... vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very ...

PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial

... Va., March 10 /PRNewswire/ -- PARI's LC STAR nebulizer and PRONEB Ultra II compressor are the exclusive ... Equipment. "Our LC STAR is a fine particle nebulizer that enables delivery of aerosols to the smaller ... . The combination of PARI's LC STAR nebulizer and PRONEB Ultra II compressor provides for a ...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

... 26 /PRNewswire/ -- PARI Pharma's eFlow electronic nebulizer was included in Gilead's (Nasdaq: GILD ) recent ... that produce the aerosol mist. Compared to other nebulizer systems, eFlow can produce aerosols with a ... inhalation drug development, including nebulizer formulation development and optimization, ...

Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis

... of levofloxacin inhaled solution delivered by an Investigational eFlow nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary ... of MP-376 when administered by inhalation using an Investigational eFlow nebulizer System. All patients were required to be culture positive for P. ...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

... Pseudomonas aeruginosa. Administration of MP-376 with a high efficiency nebulizer to the lungs allows for the delivery of high concentrations of active drug ... Nebulizer, developed by PARI Pharma GmbH. eFlow(R) is a quiet portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG

... proprietary Fluidosomes technology with the well-established generic drug tobramycin. Utilising synthetic liposomes containing tobramycin, a standard nebulizer delivers the drug directly to the endobronchial sites of infection in cystic fibrosis patients. This may result in prolonged high local drug ...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

... Arikace is delivered by a novel inhalation device, the eFlow(R) Electronic Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications, including liposomal formulations such as Arikace, via a vibrating perforated membrane. ...

Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference

... that provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Hospital-acquired, gram-negative bacterial pneumonia is ... which provides key advantages over traditional pneumatic or ultra-sonic nebulizer delivery. Sources: ...

PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin

... liquid medications via a vibrating, perforated membrane. Compared to other nebulizer systems, eFlow can produce aerosols with a very high density of active ... PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and optimization, CMC, analytics, aerosol ...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... in the United States and Europe. About PARI and the eFlow Electronic nebulizer Aztreonam lysine is delivered through a novel inhalation device, the ... developed by PARI Pharma GmbH. The eFlow is an electronic, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

... the United States and Europe. About PARI Pharma and the eFlow Electronic nebulizer Aztreonam lysine for inhalation is delivered by a novel inhalation ... Nebulizer, developed by PARI Pharma GmbH. eFlow is a quiet, portable nebulizer that enables efficient aerosolization of liquid medications via a ...

PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference

... optimized to advanced delivery platforms, such as eFlow. Focusing on comprehensive inhalation therapy development, including optimized nebulizer formulations, analytics, and aerosol characterization, PARI Pharma has several clinical development programs ongoing, either partnered or ....
Other Contents
(Date:9/1/2014)... and decisions of the Nomenclature Section of the XVIII ... July 2011. This meeting is held every six years ... the rules for naming algae, fungi and plants get ... naming the organisms they study. This is the primary ... for algae, fungi, and plants, which was published in ...
(Date:8/31/2014)... A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria ... stomach cramps, has been developed by a team at ... the research team has demonstrated that it is possible ... which would lead to rapid diagnosis of the ... could be possible to identify different strains of the ...
(Date:8/31/2014)... of satellite data from the last 19 years reveals that ... the coast of Antarctica to rise by 2cm more than ... of Southampton detected the rapid rise in sea-level by studying ... million square kilometres. , The melting of the ... has contributed an excess of around 350 gigatonnes of freshwater ...
Breaking Biology News(10 mins):Week-long meeting on naming algae, fungi, and plants recorded for posterity 2Scientists develop 'electronic nose' for rapid detection of C. diff infection 2
(Date:9/2/2014)... Humility of Mary Health Partners will offer a ... Health Center, 1044 Belmont Ave. , The workshop includes an ... common health problems as well as tips on caring for ... on when to seek medical attention. , The morning ... Room; the evening session runs from 5:30 to 6:30 p.m. ...
(Date:9/2/2014)... 02, 2014 A little bit of ... sometimes the onset of irritability, sadness, or apathy can ... September 2014 Harvard Health Letter. , "Mood-related ... stresses. If they occur for long periods, cause significant ... to seek help," says Dr. Nancy Donovan, an instructor ...
(Date:9/2/2014)... Eric Jimenez and Leah Ashley announced ... revolutionary makeup application device. Designed to improve and accelerate ... the palm of women’s hands to help them get ... Me’s success lies in its patented technology. With a ... 15,000 pulses per minute, the device applies foundation evenly ...
(Date:9/2/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief executive officer ... Sioux Falls, S.D. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... and nationally recognized leader in patient-centered care. It is ...
(Date:9/2/2014)... Syracuse, NY (PRWEB) September 02, 2014 ... A. Gadlage, M.D. & Associates in Duluth, GA and ... the EarQ team at the 2014 National ... in Cancun, Mexico. , While interacting with the former ... maintaining hearing health, the team provided free hearing screenings, ...
Breaking Medicine News(10 mins):Health News:HMHP Offers ‘Health at Home’ Workshop 2Health News:When a Mood Swing Signals Trouble, From the September 2014 Harvard Health Letter 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 3Health News:The EarQ Team Brings Hearing Health Awareness to the 2014 National Basketball Retired Players Association Annual Convention in Cancun 2
Other TagsOther Tags